These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 13454968)
21. Use of meprobamate in tension states. FOLKSON A J Ment Sci; 1957 Oct; 103(433):860-3. PubMed ID: 13481600 [No Abstract] [Full Text] [Related]
22. Meprobamate in the treatment of tension states. HELLER GC; WALTON D; BLACK DA J Ment Sci; 1957 Jul; 103(432):581-8. PubMed ID: 13449564 [No Abstract] [Full Text] [Related]
23. A critical review of the efficacy of meprobamate (miltown, equanil) in the treatment of anxiety. LATIES VG; WEISS B J Chronic Dis; 1958 Jun; 7(6):500-19. PubMed ID: 13563590 [No Abstract] [Full Text] [Related]
25. [Methyl - propyl - propanediol dicarbonate (meprobamate) in dermatology]. KAMINSKY A; KAPLAN A; SEVINSKY B Dia Med; 1956 Oct; 28(74):2284-6. PubMed ID: 13397363 [No Abstract] [Full Text] [Related]
26. A controlled trial of meprobamate in anxious out-patients. HINTON JM J Neurol Neurosurg Psychiatry; 1958 Nov; 21(4):301-4. PubMed ID: 13611573 [No Abstract] [Full Text] [Related]
27. [Medicinal combinations in the treatment of anxiety]. FELDMANN H Schweiz Arch Neurol Psychiatr; 1958; 81(1-2):152-4. PubMed ID: 13602726 [No Abstract] [Full Text] [Related]
28. Clinical evaluation of meprobamate in disturbed and prepsychotic children. LITCHFIELD HR Ann N Y Acad Sci; 1957 May; 67(10):828-32. PubMed ID: 13459154 [No Abstract] [Full Text] [Related]
29. Electromyographic studies on meprobamate and the working, anxious patient. DICKEL HA; WOOD JA; DIXON HH Ann N Y Acad Sci; 1957 May; 67(10):780-8. PubMed ID: 13459148 [No Abstract] [Full Text] [Related]
30. [Pharmacological actions of 2-methyl-2-n-propyl-1, 3-propandiol dicarbamate. I. Actions on experimental epilepsy]. SCARINCI V Arch Ital Sci Farmacol; 1957 Apr; 7(2):113-8. PubMed ID: 13459617 [No Abstract] [Full Text] [Related]
31. [A new anxiety therapy, meprobamate]. HOSOTTE A; FERRAND M; LANTHEAUME L; GAULT R Alger Medicale; 1957 Sep; 61(9):977-84 passim. PubMed ID: 13487492 [No Abstract] [Full Text] [Related]
32. [Treatment of states of anxiety and anguish; a new drug]. JARES R; CIONE LP; RAGAZZI A Prensa Med Argent; 1956 Sep; 43(37):2781-3. PubMed ID: 13419875 [No Abstract] [Full Text] [Related]
33. [Effect of 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate) on the spinal electric potential in frogs]. RAPUZZI G; DOZIO G Arch Ital Sci Farmacol; 1958 Jan; 8(1):74-84. PubMed ID: 13522415 [No Abstract] [Full Text] [Related]
34. [Treatment of anxiety states & sleep disorders with an ataraxic]. SCHULTZE H Ther Ggw; 1957 Oct; 96(10):376-8. PubMed ID: 13496022 [No Abstract] [Full Text] [Related]
35. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent. BERGER FM J Pharmacol Exp Ther; 1954 Dec; 112(4):413-23. PubMed ID: 13222235 [No Abstract] [Full Text] [Related]
36. [Could methyl-2-N-propyl-2-propandiolo-1,3-dicarbamate (meprobamate, miltown, perequil) be ultimately used in chronic lead poisoning?]. GENTILE G Folia Med (Napoli); 1959 Jul; 42():819-24. PubMed ID: 13827321 [No Abstract] [Full Text] [Related]
37. [Meprobamate effect in cases of anxiety. (Final report)]. HVALSOE H; AAGAARD-THOMSEN K Nord Psykiatr Tidsskr; 1961; 15():138-41. PubMed ID: 13717122 [No Abstract] [Full Text] [Related]
38. A controlled study of the use of meprobamate in a mental hygiene clinic. COLEMAN EL; NELSON SE; OLSON FP; RATHS ON; WIENER DN J Clin Exp Psychopathol; 1958; 19(4):323-9. PubMed ID: 13620764 [No Abstract] [Full Text] [Related]
39. [Use of meprobamate, especially in states of anxiety in cases of intestinal diseases]. CICALA P Minerva Med; 1956 Nov; 47(88):1463-4. PubMed ID: 13387288 [No Abstract] [Full Text] [Related]